Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics

被引:0
|
作者
Giuseppe Blasi
Pierluigi Selvaggi
Leonardo Fazio
Linda Antonella Antonucci
Paolo Taurisano
Rita Masellis
Raffaella Romano
Marina Mancini
Fengyu Zhang
Grazia Caforio
Teresa Popolizio
Jose Apud
Daniel R Weinberger
Alessandro Bertolino
机构
[1] Group of Psychiatric Neuroscience,Department of Basic Medical Sciences
[2] Neuroscience and Sense Organs,Department of Education Science
[3] University of Bari ‘Aldo Moro’,undefined
[4] IRCCS ‘Casa Sollievo della Sofferenza’,undefined
[5] Psychology,undefined
[6] Communication Science,undefined
[7] Aldo Moro University,undefined
[8] Lieber Institute for Brain Development,undefined
[9] Johns Hopkins Medical Campus,undefined
[10] National Institutes of Health,undefined
[11] National Institute of Mental Health,undefined
[12] Clinical Brain Disorders Branch,undefined
[13] pRED,undefined
[14] NORD DTA,undefined
[15] F. Hoffman-La Roche Ltd.,undefined
来源
Neuropsychopharmacology | 2015年 / 40卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Dopamine D2 and serotonin 5-HT2A receptors contribute to modulate prefrontal cortical physiology and response to treatment with antipsychotics in schizophrenia. Similarly, functional variation in the genes encoding these receptors is also associated with these phenotypes. In particular, the DRD2 rs1076560 T allele predicts a lower ratio of expression of D2 short/long isoforms, suboptimal working memory processing, and better response to antipsychotic treatment compared with the G allele. Furthermore, the HTR2A T allele is associated with lower 5-HT2A expression, impaired working memory processing, and poorer response to antipsychotics compared with the C allele. Here, we investigated in healthy subjects whether these functional polymorphisms have a combined effect on prefrontal cortical physiology and related cognitive behavior linked to schizophrenia as well as on response to treatment with second-generation antipsychotics in patients with schizophrenia. In a total sample of 620 healthy subjects, we found that subjects with the rs1076560 T and rs6314 T alleles have greater fMRI prefrontal activity during working memory. Similar results were obtained within the attentional domain. Also, the concomitant presence of the rs1076560 T/rs6314 T alleles also predicted lower behavioral accuracy during working memory. Moreover, we found that rs1076560 T carrier/rs6314 CC individuals had better responses to antipsychotic treatment in two independent samples of patients with schizophrenia (n=63 and n=54, respectively), consistent with the previously reported separate effects of these genotypes. These results indicate that DRD2 and HTR2A genetic variants together modulate physiological prefrontal efficiency during working memory and also modulate the response to antipsychotics. Therefore, these results suggest that further exploration is needed to better understand the clinical consequences of these genotype–phenotype relationships.
引用
收藏
页码:1600 / 1608
页数:8
相关论文
共 50 条
  • [1] Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics
    Blasi, Giuseppe
    Selvaggi, Pierluigi
    Fazio, Leonardo
    Antonucci, Linda Antonella
    Taurisano, Paolo
    Masellis, Rita
    Romano, Raffaella
    Mancini, Marina
    Zhang, Fengyu
    Caforio, Grazia
    Popolizio, Teresa
    Apud, Jose
    Weinberger, Daniel R.
    Bertolino, Alessandro
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 (07) : 1600 - 1608
  • [2] Novel, highly potent and selective serotonin 5-HT2A/dopamine D2 receptor antagonists as potential antipsychotics.
    Lee, TK
    Robichaud, AJ
    Boyle, KE
    Lu, YM
    Chen, WT
    McClung, C
    Deng, W
    Miller, KJ
    McElroy, JF
    Largent, BL
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U17 - U17
  • [3] Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects
    Karlsson, P
    Dencker, E
    Nyberg, S
    Mannaert, E
    Boom, S
    Talluri, K
    Rossenu, S
    Eriksson, B
    Eerdekens, M
    Farde, L
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S386 - S386
  • [4] Pharmacokinetics and dopamine D2 and serotonin 5-HT2A receptor occupancy of paliperidone in healthy subjects
    Karlsson, P
    Dencker, E
    Nyberg, S
    Cselenyi, Z
    Mannaert, E
    Boom, S
    Talluri, K
    Rossenu, S
    Eriksson, B
    Eerdekens, M
    Farde, L
    [J]. SCHIZOPHRENIA RESEARCH, 2006, 81 : 85 - 86
  • [5] Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors
    Albizu, Laura
    Holloway, Terrell
    Gonzalez-Maeso, Javier
    Sealfon, Stuart C.
    [J]. NEUROPHARMACOLOGY, 2011, 61 (04) : 770 - 777
  • [6] Hetero-dimerization of serotonin 5-HT2A and dopamine D2 receptors
    Lukasiewicz, Sylwia
    Polit, Agnieszka
    Kendracka-Krok, Sylwia
    Wedzony, Krzysztof
    Mackowiak, Marzena
    Dziedzicka-Wasylewska, Marta
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2010, 1803 (12): : 1347 - 1358
  • [7] Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density
    Lian, Jiamei
    Huang, Xu-Feng
    Pai, Nagesh
    Deng, Chao
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 47 : 62 - 68
  • [8] A NOVEL CELL LINE FOR STUDYING DOPAMINE D2 AND SEROTONIN 5-HT2A HETERODIMERIZATION
    Gomez Fernandez, S.
    Lopez-Gimenez, J. F.
    Varela, M. J.
    Marcia-Rivas, M. D.
    Cadavid, M., I
    Brea, J.
    Loza, M., I
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 : 38 - 38
  • [9] New hexahydrocarbazoles and spiro indoles, and their affinity for D2 dopamine and 5-HT2A serotonin receptors
    Fernández, F
    García-Mera, X
    Rodríguez, G
    Urrutia, A
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1999, 47 (07) : 1006 - 1009
  • [10] Effect of clozapine on the dimerization of serotonin 5-HT2A receptor and its genetic variant 5-HT2AH425Y with dopamine D2 receptor
    Lukasiewicz, Sylwia
    Faron-Gorecka, Agata
    Kedracka-Krok, Sylwia
    Dziedzicka-Wasylewska, Marta
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 659 (2-3) : 114 - 123